Your browser doesn't support javascript.
loading
Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review.
Goode, Adam P; Coeytaux, Remy R; Maslow, Gary R; Davis, Naomi; Hill, Sherika; Namdari, Behrouz; LaPointe, Nancy M Allen; Befus, Deanna; Lallinger, Kathryn R; Bowen, Samantha E; Kosinski, Andrzej; McBroom, Amanda J; Sanders, Gillian D; Kemper, Alex R.
Afiliación
  • Goode AP; Duke Orthopaedic Surgery.
  • Coeytaux RR; Duke Clinical Research Institute, and.
  • Maslow GR; Department of Family and Community Medicine and.
  • Davis N; Center of Integrative Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
  • Hill S; Departments of Psychiatry and Behavioral Sciences.
  • Namdari B; Pediatrics, and.
  • LaPointe NMA; Departments of Psychiatry and Behavioral Sciences.
  • Befus D; Departments of Psychiatry and Behavioral Sciences.
  • Lallinger KR; Departments of Psychiatry and Behavioral Sciences.
  • Bowen SE; Medicine.
  • Kosinski A; Premier, Inc, Charlotte, North Carolina.
  • McBroom AJ; Center of Integrative Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina.
  • Sanders GD; Duke Clinical Research Institute, and.
  • Kemper AR; Duke Evidence-Based Practice Center, Durham, North Carolina; and.
Pediatrics ; 141(6)2018 06.
Article en En | MEDLINE | ID: mdl-29848556
CONTEXT: Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral interventions to complementary medicines. OBJECTIVES: To assess the comparative effectiveness of nonpharmacologic treatments for ADHD among individuals 17 years of age and younger. DATA SOURCES: PubMed, Embase, PsycINFO, and Cochrane Database of Systematic Reviews for relevant English-language studies published from January 1, 2009 through November 7, 2016. STUDY SELECTION: We included studies that compared any ADHD nonpharmacologic treatment strategy with placebo, pharmacologic, or another nonpharmacologic treatment. DATA EXTRACTION: Study design, patient characteristics, intervention approaches, follow-up times, and outcomes were abstracted. For comparisons with at least 3 similar studies, random-effects meta-analysis was used to generate pooled estimates. RESULTS: We identified 54 studies of nonpharmacologic treatments, including neurofeedback, cognitive training, cognitive behavioral therapy, child or parent training, dietary omega fatty acid supplementation, and herbal and/or dietary approaches. No new guidance was identified regarding the comparative effectiveness of nonpharmacologic treatments. Pooled results for omega fatty acids found no significant effects for parent rating of ADHD total symptoms (n = 411; standardized mean difference -0.32; 95% confidence interval -0.80 to 0.15; I2 = 52.4%; P = .10) or teacher-rated total ADHD symptoms (n = 287; standardized mean difference -0.08; 95% confidence interval -0.47 to 0.32; I2 = 0.0%; P = .56). LIMITATIONS: Studies often did not reflect the primary care setting and had short follow-up periods, small sample sizes, variations in outcomes, and inconsistent reporting of comparative statistical analyses. CONCLUSIONS: Despite wide use, there are significant gaps in knowledge regarding the effectiveness of ADHD nonpharmacologic treatments.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Pediatrics Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno por Déficit de Atención con Hiperactividad Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Pediatrics Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos